Loading...
Market
What will be the biotech community's response to RFK Jr.'s proposal by March 2025?
2
Resolution / Starting Odds
Mostly supportive • 25%
Mostly opposed • 25%
Mixed reactions • 25%
No significant response • 25%
Public statements or press releases from major biotech companies or industry groups
Story
RFK Jr. Proposes Eight-Year Pause on NIH Infectious Disease Research, Redirecting to Chronic Diseases
Nov 17, 2024, 12:25 PM
Robert F. Kennedy Jr. has proposed an eight-year pause on NIH-funded infectious disease research, redirecting efforts towards chronic diseases. Kennedy expressed gratitude to NIH scientists for their public service, stating, 'God bless you all. Thank you for public service. We’re going to give infectious disease a break for about eight years,' NBC News reported. This proposal has sparked concern among experts, including Dr. Mandy Cohen, director of the CDC, who emphasized that 'viruses don’t pay attention to the political cycles.' The biotech community has also shown mixed reactions, with some founders questioning the impact of halting government funding for drug development, especially for diseases like COVID-19 and measles, despite significant evidence of infections as candidates for chronic illness cause.
View original story
Similar markets
Supportive • 25%
Opposed • 25%
Neutral • 25%
Mixed • 25%
Launches public campaign • 25%
Engages in lobbying efforts • 25%
No significant response • 25%
Other actions • 25%
Mostly support • 25%
Mostly oppose • 25%
Neutral • 25%
Unaware • 25%
Full implementation • 25%
Partial implementation • 25%
No implementation • 25%
Reversal or cancellation • 25%
Strong opposition • 25%
Moderate opposition • 25%
Support • 25%
Neutral • 25%
Supportive • 25%
Opposed • 25%
Neutral • 25%
No Comment • 25%
Strong Support • 25%
Cautious Support • 25%
Concern • 25%
Strong Opposition • 25%
Acknowledges concerns • 25%
Rejects concerns • 25%
No public response • 25%
Other • 25%
Appointed and active • 25%
Appointed but inactive • 25%
Not appointed • 25%
Other outcome • 25%
Yes • 50%
No • 50%
Implemented • 25%
Modified • 25%
Rejected • 25%
No significant changes • 25%
